{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260625276927/en/Glaukos-Announces-Completion-of-Patient-Enrollment-in-Phase-2-Study-of-GLK-321-for-Demodex-Blepharitis", "message": "News view counter 816213 successfully enlarged"}